Get Your Personalized Supplement StackSupplement Stack Quiz

Sceletium Tortuosum Extract

Also known as: Kanna, Channa, Kougoed, Mesembryanthemum tortuosum, Zembrin, Sceletium tortuosum

Overview

Sceletium tortuosum, commonly known as Kanna, is a succulent plant native to South Africa, historically used by indigenous communities for its mood-enhancing and anxiety-reducing properties. Standardized extracts, such as Zembrin, contain key alkaloids like mesembrine, mesembrenone, and mesembrenol, which are responsible for its pharmacological effects. It is primarily used as a botanical supplement to promote overall well-being, alleviate anxiety, improve mood, and enhance cognitive function. Research on Sceletium tortuosum is moderately mature, with several randomized controlled trials and a systematic review supporting its anxiolytic and cognitive benefits, though studies often feature modest sample sizes. The evidence quality is promising, indicating its potential as a natural psychotropic agent.

Benefits

Sceletium tortuosum extract has demonstrated several evidence-based benefits. It exhibits significant anxiolytic effects, as shown in a double-blind, placebo-controlled fMRI study where a single 25 mg dose of Zembrin reduced amygdala reactivity to fearful stimuli and decreased amygdala-hypothalamus connectivity, suggesting a reduction in threat response. This indicates its potential for managing anxiety. Furthermore, a randomized, double-blind, placebo-controlled crossover study found that daily 25 mg Zembrin improved cognitive set flexibility and executive function in healthy adults, alongside positive effects on mood and sleep. Preclinical research also suggests potential antidepressant and anti-inflammatory properties through monoamine regulation, though these require further clinical validation. A recent systematic review and meta-analysis further confirms the anxiolytic effects of S. tortuosum extracts, reinforcing its utility in mood and anxiety support.

How it works

Sceletium tortuosum extract exerts its effects primarily through a dual mechanism of action: it acts as a phosphodiesterase-4 (PDE4) inhibitor and a serotonin (5-HT) reuptake inhibitor. Alkaloids like mesembrine are thought to inhibit serotonin reuptake, increasing serotonin availability in the synaptic cleft, which is crucial for mood regulation. Mesembrenone and mesembrenol contribute to PDE4 inhibition, leading to increased intracellular cyclic AMP (cAMP) levels, which can modulate neuronal excitability and plasticity. These combined actions enhance serotonergic neurotransmission and influence intracellular signaling pathways involved in mood and cognition. This modulation helps reduce amygdala hyperactivity, a brain region associated with fear and anxiety, and optimizes neurocircuitry involved in executive function. Oral administration of standardized extracts at 25 mg has shown efficacy in humans.

Side effects

Sceletium tortuosum extract, particularly the standardized form Zembrin, is generally well tolerated at therapeutic doses (25 mg daily) with no serious adverse events reported in clinical trials. Common side effects are minimal or absent. While no significant drug interactions have been formally documented, caution is advised when combining Sceletium tortuosum with other serotonergic agents, such as antidepressants (SSRIs, SNRIs), due to the potential for additive effects and a theoretical risk of serotonin syndrome, although this has not been clinically observed. Contraindications are not well-established, but individuals with severe psychiatric disorders, pregnant or breastfeeding women, and children should avoid use due to insufficient research in these populations. It is always recommended to consult a healthcare professional before starting any new supplement, especially if on existing medications or having underlying health conditions.

Dosage

The recommended and clinically effective dosage for Sceletium tortuosum extract, specifically the standardized Zembrin, is 25 mg once daily. This dosage has been consistently used in clinical studies to demonstrate both acute anxiolytic effects and chronic cognitive benefits. Acute anxiolytic effects may be observed within hours of a single dose, while improvements in cognitive function and mood typically require consistent daily administration over several weeks. There is no established maximum safe dose, as clinical trials have not exceeded 25 mg daily. The extract can be taken orally with or without food. No specific absorption cofactors have been identified as necessary for its efficacy. Adhering to the recommended 25 mg daily dose is crucial, as higher doses have not been studied for safety or increased efficacy.

FAQs

Is Sceletium tortuosum safe?

Yes, clinical trials report good tolerability at 25 mg daily with minimal side effects. No serious adverse events have been reported in studies.

How quickly does it work?

Acute anxiolytic effects can occur after a single dose, often within hours. Cognitive improvements, however, typically require repeated daily dosing over several weeks.

Can it be combined with antidepressants?

Caution is advised due to its serotonergic activity. While no direct interaction studies exist, consult a healthcare professional before combining with other serotonergic agents.

Is it effective for depression?

Preliminary preclinical evidence suggests potential antidepressant effects, but robust clinical trials specifically for depression are currently lacking. More research is needed.

What is the recommended daily dose?

The clinically studied and recommended dose for standardized Sceletium tortuosum extract (Zembrin) is 25 mg once daily.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC3828542/ – This double-blind, placebo-controlled fMRI study with 16 healthy adults found that a single 25 mg dose of Zembrin reduced amygdala reactivity to fearful faces and decreased amygdala-hypothalamus connectivity. This suggests an anxiolytic potential by modulating threat processing in the brain, despite the small sample size.
https://onlinelibrary.wiley.com/doi/10.1155/2014/682014 – A randomized, double-blind, placebo-controlled crossover RCT involving 21 healthy adults (mean age 54.6) showed that 25 mg daily of Zembrin for 3 weeks improved cognitive set flexibility and executive function. Participants also reported improved mood and sleep, and the supplement was well tolerated, though the sample was small and specific to middle-aged healthy subjects.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12249403/ – This preclinical and chemical profiling study identified the alkaloid composition of Sceletium tortuosum, including mesembrine, mesembrenone, and mesembrenol. It suggested that these compounds contribute to monoamine regulation and anti-inflammatory mechanisms, providing a foundational understanding of the plant's potential pharmacological actions, though it lacks direct clinical outcomes.
https://ouci.dntb.gov.ua/en/works/4EwdZJz9/ – This systematic review and meta-analysis confirmed the anxiolytic effects of Sceletium tortuosum extracts based on an aggregation of multiple studies. While it provides high-level evidence for its efficacy in reducing anxiety, specific details on effect sizes and confidence intervals were not provided in the summary, necessitating a full text review for detailed appraisal.